<DOC>
	<DOCNO>NCT00057681</DOCNO>
	<brief_summary>This study evaluate effectiveness medication , lithium ( Eskalith® ) , valproate ( Depakote® ) , risperidone ( Risperdal® ) treat child adolescent bipolar disorder symptom mania .</brief_summary>
	<brief_title>Study Outcome Safety Lithium , Divalproex Risperidone Mania Children Adolescents</brief_title>
	<detailed_description>Patients randomly assign receive lithium ( Eskalith ) , valproate ( Depakote ) , risperidone ( Risperdal ) 8 16 week . They weekly visit monitor response medication . When study complete , care transfer child 's treating psychiatrist .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>DSMIV criterion bipolar I ( manic mixed ) mania least 4 week CGAS less equal 60 Good physical health Schizophrenia pervasive developmental disorder Major medical neurological disease History addiction illicit substance alcohol drug abuse within last 4 week IQ le 70 Pregnancy breastfeed Unacceptable method contraception Inpatient care baseline</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Mania</keyword>
</DOC>